Treatment of chronic glomerulonephritis with a combination of indomethacin and cyclophosphamide
- PMID: 1204260
Treatment of chronic glomerulonephritis with a combination of indomethacin and cyclophosphamide
Abstract
33 cases of chronic glomerulonephritis who responded unsatisfactorily to treatment with indomethacin alone were treated in addition with a low dose of cyclophosphamide. The five patients with focal glomerulosclerosis responded poorly. The remaining 28 patients showed a statistically significant improvement in renal function and proteinuria.
Similar articles
-
[Treatment of chronic glomerulonephritis using indomethacin and small doses of cyclophosphamide].J Urol Nephrol (Paris). 1975 Apr-May;81(4-5):281-90. J Urol Nephrol (Paris). 1975. PMID: 1159887 French. No abstract available.
-
Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.Clin Nephrol. 1976 Mar;5(3):105-13. Clin Nephrol. 1976. PMID: 1261101
-
Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.Clin Nephrol. 1987 Feb;27(2):56-64. Clin Nephrol. 1987. PMID: 3549083 Clinical Trial.
-
[Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].Z Urol Nephrol. 1985 Jan;78(1):39-55. Z Urol Nephrol. 1985. PMID: 3976309 German.
-
[Therapy of primary chronic glomerulonephritis].Ther Umsch. 1994 Dec;51(12):807-12. Ther Umsch. 1994. PMID: 7784993 Review. German.
Cited by
-
Transition of children with membranoproliferative glomerulonephritis to adolescence and adulthood.Clin Exp Nephrol. 2008 Feb;12(1):28-32. doi: 10.1007/s10157-007-0014-5. Epub 2008 Jan 5. Clin Exp Nephrol. 2008. PMID: 18175061
-
Antiplatelet drugs: clinical pharmacology and therapeutic use.Drugs. 1979 Dec;18(6):439-77. doi: 10.2165/00003495-197918060-00002. Drugs. 1979. PMID: 391530 Review.
-
Idiopathic membranoproliferative glomerulonephritis in Japanese children.Pediatr Nephrol. 1995 Jun;9(3):272-7. doi: 10.1007/BF02254182. Pediatr Nephrol. 1995. PMID: 7632509
-
Renal survival in membranoproliferative glomerulonephritis (MPGN): role of long-term treatment with non-steroid anti-inflammatory drugs (NSAID).Int Urol Nephrol. 1988;20(6):669-77. doi: 10.1007/BF02549501. Int Urol Nephrol. 1988. PMID: 3229937